US clinical guidelines from organizations such as the American Diabetes Association (ADA), American Gastroenterological Association (AGA), and Endocrine Society recommend continuing effective anti-obesity medication therapy as long as it remains beneficial, well-tolerated, and medically appropriate
No basis for a Therapeutic Use Exemption
Similar clinical symptoms are found in individuals with hereditary IF deficiency (also called congenital pernicious anemia) in whom the lack of IF results in the defective absorption of vitamin B 12
Then theres the cagrilintide semaglutide combination, CagriSema (Novo Nordisk), which has been in the news a lot
This is because vitamin B12 plays an important role in helping your cells use nutrients and perform metabolic functions
The switching dosage chart and dose conversion chart resources provide the dosage guidance that complements the plotter's visual timeline